Amicus Therapeutics, Inc. (FOLD)

[ghmm]

Key Milestones from todays LCM presentation


Amigal for Fabry
2H 2008: Update regarding US and EU regulatory discussions and Phase 3 plans
Q1 2009: Phase 2 extension data
1H 2009: Initiation of Phase 3 registration study

Plicera for Gaucher
2H 2009: Results from 6 month study in ERT naive patients

AT2220 for Pompe
1Q 2009: Additional results of ERT-Chaperone preclinical combination studies
2H 2009: Results from 11 week study in ERT naive adult patients

The shire HGT day had some coverage as well. They gave a bit more color on time-line> I caught the Pompe and Gauche results as mid 09 rather then 2H.